Key Financial Data Of Group

Pharmarise Holdings Corporation - Filing #7289113

Concept As at
2024-11-30
2024-06-01 to
2024-11-30
2023-06-01 to
2024-05-31
As at
2024-05-31
As at
2023-11-30
2023-06-01 to
2023-11-30
Key financial data of group
Business results of group
Net sales
30,544,000,000 JPY
54,466,000,000 JPY
26,948,000,000 JPY
Ordinary profit (loss)
29,000,000 JPY
833,000,000 JPY
701,000,000 JPY
Profit (loss) attributable to owners of parent
-113,000,000 JPY
-351,000,000 JPY
273,000,000 JPY
Comprehensive income
-125,000,000 JPY
-325,000,000 JPY
283,000,000 JPY
Net assets
7,163,000,000 JPY
7,442,000,000 JPY
8,391,000,000 JPY
Total assets
30,457,000,000 JPY
29,486,000,000 JPY
22,966,000,000 JPY
Basic earnings (loss) per share
-10.09
-33.41
28.29
Diluted earnings per share
26.99
Equity-to-asset ratio
0.226 xbrli:pure
0.243 xbrli:pure
0.353 xbrli:pure
Net cash provided by (used in) operating activities
-200,000,000 JPY
2,714,000,000 JPY
1,860,000,000 JPY
Net cash provided by (used in) investing activities
-537,000,000 JPY
-3,120,000,000 JPY
-543,000,000 JPY
Net cash provided by (used in) financing activities
1,138,000,000 JPY
2,771,000,000 JPY
-1,128,000,000 JPY
Cash and cash equivalents
7,504,000,000 JPY
7,100,000,000 JPY
4,923,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.